Cision PR Newswire

Manulife Closes Long-Term Care Reinsurance Transaction with Munich Re

TORONTO, Oct. 2, 2026 /PRNewswire/ -- Manulife Financial Corporation ("Manulife" or the "Company") announced today that it has closed1 the previously announced transaction to reinsure biometric risk...

AIKO and Next Green Group Power Melbourne Sports and Aquatic Centre with 1.3 MW Rooftop Solar System

Shade-tolerant ABC modules and a flush-mount design unlock around 53% more capacity than tendered...

AhaSlides wins 2026 Training Magazine Network Choice Award for Gamification & Game-Based Learning

Voted by L&D professionals, the award caps a year in which AhaSlides went all...

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

Includes worldwide license to ABO2203, Abogen's mRNA-encoded CD19xCD3 T-Cell Engager Agreement also...

Tech Week Singapore 2026 Spotlights the Infrastructure Powering Asia’s Next Digital Frontier

The two-day event brought together 38,000 attendees and 720 international exhibitors, alongside the launch...

TECNO Unveils Industry’s Lightest OLED Laptop MEGABOOK S14 at MWC 2025 with TECNO AI and Snapdragon X Elite Compute Platform

BARCELONA, Spain, March 5, 2025 /PRNewswire/ -- On March 4, 2025, Innovative AI-driven technology brand TECNO unveiled its new MEGABOOK S14 – the industry's lightest...

Telkomcel Holds TAIS 2025, Strengthens Commitment to Innovation and Digital Transformation

DILI, Timor-Leste, March 5, 2025 /PRNewswire/ -- Telkomcel has reaffirmed its commitment to driving innovation and accelerating digital transformation in Timor-Leste through the organization...

Business Plan Contest “Photonics Challenge 2025” was Successfully Held in Hamamatsu City, the Center of the Optical Industry

Three companies with outstanding optical technology – Beyond Optical Medical Technologies, Ectobrain Devices and Catana Corporation – presented groundbreaking ideas and are awarded for their...

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland

CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small,...